Lazennec G - Search Results

1

Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators.

Lazennec G, Thomas JA, Katzenellenbogen BS. Lazennec G, et al. J Steroid Biochem Mol Biol. 2001 Jun;77(4-5):193-203. doi: 10.1016/s0960-0760(01)00060-7. J Steroid Biochem Mol Biol. 2001. PMID: 11457657

2

The nuclear orphan receptors COUP-TF and ARP-1 positively regulate the trout estrogen receptor gene through enhancing autoregulation.

Lazennec G, Kern L, Valotaire Y, Salbert G. Lazennec G, et al. Mol Cell Biol. 1997 Sep;17(9):5053-66. doi: 10.1128/mcb.17.9.5053. Mol Cell Biol. 1997. PMID: 9271383 Free PMC article.

3

Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter.

Lazennec G, Kern L, Salbert G, Saligaut D, Valotaire Y. Lazennec G, et al. Mol Endocrinol. 1996 Sep;10(9):1116-26. doi: 10.1210/mend.10.9.8885246. Mol Endocrinol. 1996. PMID: 8885246

4

Characterization of an estrogen-responsive element implicated in regulation of the rainbow trout estrogen receptor gene.

Le Dréan Y, Lazennec G, Kern L, Saligaut D, Pakdel F, Valotaire Y. Le Dréan Y, et al. Among authors: lazennec g. J Mol Endocrinol. 1995 Aug;15(1):37-47. doi: 10.1677/jme.0.0150037. J Mol Endocrinol. 1995. PMID: 8546812

5

Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.

Lazennec G, Canaple L, Saugy D, Wahli W. Lazennec G, et al. Mol Endocrinol. 2000 Dec;14(12):1962-75. doi: 10.1210/mend.14.12.0575. Mol Endocrinol. 2000. PMID: 11117527 Free PMC article.

6

Estrogen receptors: selective ligands, partners, and distinctive pharmacology.

Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA. Katzenellenbogen BS, et al. Among authors: lazennec g. Recent Prog Horm Res. 2000;55:163-93; discussion 194-5. Recent Prog Horm Res. 2000. PMID: 11036937 Review.

7

Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation.

Lazennec G, Alcorn JL, Katzenellenbogen BS. Lazennec G, et al. Mol Endocrinol. 1999 Jun;13(6):969-80. doi: 10.1210/mend.13.6.0318. Mol Endocrinol. 1999. PMID: 10379895

8

Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.

Lazennec G, Katzenellenbogen BS. Lazennec G, et al. Mol Cell Endocrinol. 1999 Mar 25;149(1-2):93-105. doi: 10.1016/s0303-7207(98)00254-8. Mol Cell Endocrinol. 1999. PMID: 10375022

9

Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.

Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS. Weis KE, et al. Among authors: lazennec g. Mol Endocrinol. 1996 Nov;10(11):1388-98. doi: 10.1210/mend.10.11.8923465. Mol Endocrinol. 1996. PMID: 8923465

10

Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.

Lazennec G, Ediger TR, Petz LN, Nardulli AM, Katzenellenbogen BS. Lazennec G, et al. Mol Endocrinol. 1997 Aug;11(9):1375-86. doi: 10.1210/mend.11.9.9983. Mol Endocrinol. 1997. PMID: 9259327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results